| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_143ac4fbe1e063c6a828a96cfffc34d5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4891 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 |
| filingDate |
2019-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b231376d0a664327cc117fbdc854ca72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45754ad79df0cee87e1ebbd35792fab1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6671d75d1900f6aa01bf25f8416e16f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59f88e73bbb3e844fc23ce2a291283b9 |
| publicationDate |
2021-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20210047779-A |
| titleOfInvention |
Sustained-Release Minimized Oral Dosage Formulation Comprising Choline Alfoscerate |
| abstract |
The present invention provides a novel pharmaceutical composition containing choline alfoscerate. In addition, the present invention provides a pharmaceutical composition containing choline alfoscerate having immediate-release and sustained-release properties, respectively, and sufficient pharmacological effects can be achieved by taking these immediate-release and sustained-release pharmaceutical compositions together orally by taking them once a day. . |
| priorityDate |
2019-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |